BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goldman HB, Lloyd JC, Noblett KL, Carey MP, Castaño Botero JC, Gajewski JB, Lehur PA, Hassouna MM, Matzel KE, Paquette IM, de Wachter S, Ehlert MJ, Chartier-Kastler E, Siegel SW. International Continence Society best practice statement for use of sacral neuromodulation. Neurourol Urodyn 2018;37:1823-48. [PMID: 29641846 DOI: 10.1002/nau.23515] [Cited by in Crossref: 55] [Cited by in F6Publishing: 36] [Article Influence: 13.8] [Reference Citation Analysis]
Number Citing Articles
1 Gevelinger MM, Sanderson DJ, Jaworski E, Doyle PJ. Evaluation of Sacral Nerve Stimulation Device Revision and Explantation in a Single Center, Multidisciplinary Study. Neuromodulation: Technology at the Neural Interface 2020;23:1201-6. [DOI: 10.1111/ner.13050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sudol NT, Brueseke TJ, Lo A, Noblett KL. Concomitant Sacral Neuromodulation and Gynecologic Surgery: A Single-Institution Experience. Neuromodulation 2020;23:1215-9. [PMID: 31840322 DOI: 10.1111/ner.13087] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Hendrickson WK, Amundsen CL. Sacral neuromodulation: troubleshooting needle placement. Int Urogynecol J 2021;32:2549-51. [PMID: 33416966 DOI: 10.1007/s00192-020-04614-9] [Reference Citation Analysis]
4 Pezzella A, McCrery R, Lane F, Benson K, Taylor C, Padron O, Blok B, de Wachter S, Gruenenfelder J, Pakzad M, Perrouin-Verbe MA, van Kerrebroeck P, Mangel J, Peters K, Kennelly M, Shapiro A, Lee U, Comiter C, Mueller M, Goldman HB. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system. Neurourol Urodyn 2021;40:714-21. [PMID: 33508155 DOI: 10.1002/nau.24615] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
5 Szymański JK, Słabuszewska-Jóźwiak A, Zaręba K, Jakiel G. Neuromodulation - a therapeutic option for refractory overactive bladder. A recent literature review. Wideochir Inne Tech Maloinwazyjne 2019;14:476-85. [PMID: 31908692 DOI: 10.5114/wiitm.2019.85352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Vaganée D, Voorham J, Panicker JN, Fransen E, Voorham-van der Zalm P, Van de Borne S, De Wachter S. Neural pathway of bellows response during SNM treatment revisited: Conclusive evidence for direct efferent motor response. Neurourol Urodyn 2020;39:1576-83. [PMID: 32484961 DOI: 10.1002/nau.24408] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Chermansky C, Schurch B, Rahnama'i MS, Averbeck MA, Malde S, Mancini V, Valentini F, Sahai A. How can we better manage drug‐resistant OAB/DO? ICI‐RS 2018. Neurourology and Urodynamics 2019;38. [DOI: 10.1002/nau.24055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Baron M, Perrouin-Verbe MA, Lacombe S, Paret F, Le Normand L, Cornu JN. Efficacy and tolerance of botulinum toxin injections after sacral nerve stimulation failure for idiopathic overactive bladder. Neurourol Urodyn 2020;39:1012-9. [PMID: 32108383 DOI: 10.1002/nau.24326] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zegrea A, Kirss J, Pinta T, Rautio T, Varpe P, Kairaluoma M, Aho M, Böckelman C, Lavonius M. Outcomes of sacral neuromodulation for chronic pelvic pain: a Finnish national multicenter study. Tech Coloproctol 2020;24:215-20. [PMID: 31965400 DOI: 10.1007/s10151-020-02148-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 De Wachter S, Knowles CH, Elterman DS, Kennelly MJ, Lehur PA, Matzel KE, Engelberg S, Van Kerrebroeck PEV. New Technologies and Applications in Sacral Neuromodulation: An Update. Adv Ther 2020;37:637-43. [PMID: 31875299 DOI: 10.1007/s12325-019-01205-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
11 Vaganée D, Kessler TM, Van de Borne S, De Win G, De Wachter S. Sacral neuromodulation using the standardized tined lead implantation technique with a curved vs a straight stylet: 2-year clinical outcomes and sensory responses to lead stimulation. BJU Int 2019;123:E7-E13. [DOI: 10.1111/bju.14650] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
12 Geynisman-Tan J, Mueller MG, Kenton KS. Satisfaction with a rechargeable sacral neuromodulation system-A secondary analysis of the ARTISAN-SNM study. Neurourol Urodyn 2021;40:549-54. [PMID: 33326643 DOI: 10.1002/nau.24596] [Reference Citation Analysis]
13 Le Fouler A, Duchalais E, Loong T, Baayen C, Wyart V, Kubis C, Meurette G, Lehur P. Long-Term Outcome Following Implanted Pulse Generator Change in Patients Treated With Sacral Nerve Modulation for Fecal Incontinence: Outcome after SNM IPG replacement. Neuromodulation: Technology at the Neural Interface 2018;21:694-9. [DOI: 10.1111/ner.12806] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Agnello M, Vottero M, Bertapelle P. Removal of sacral neuromodulation quadripolar tined-lead using a straight stylet: description of a surgical technique. Tech Coloproctol 2021;25:957-63. [PMID: 33886009 DOI: 10.1007/s10151-020-02403-6] [Reference Citation Analysis]
15 Gandhi S, Gajewski JB, Koziarz A, Almutairi S, Ali A, Cox A. Long-term outcomes of sacral neuromodulation for lower urinary tract dysfunction: A 23-year experience. Neurourol Urodyn 2021;40:461-9. [PMID: 33232534 DOI: 10.1002/nau.24583] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Rueb J, Fascelli M, Goldman HB, Vasavada S, Rackley R, Moore C, Gill B. The role of pulse width manipulation compared to program changes alone for unsatisfactory sacral neuromodulation therapy: A retrospective matched-cohort analysis. Neurourol Urodyn 2021;40:522-8. [PMID: 33305838 DOI: 10.1002/nau.24593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Averbeck MA, Moreno-Palacios J, Aparicio A. Is there a role for sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction? Int Braz J Urol 2020;46:891-901. [PMID: 32758301 DOI: 10.1590/S1677-5538.IBJU.2020.99.10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
18 Feldkamp A, Amasyalı AS, Groegler J, Jellison F, Staack A. Evaluation of progression from first to second stage sacral neuromodulation and unplanned device removal. Turk J Urol 2021;47:58-65. [PMID: 33112732 DOI: 10.5152/tud.2020.20288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Schönburg S, Bukethal T, Fornara P. Does age alone negatively predict the outcome of sacral neuromodulation? A single-centre retrospective observational study. BMC Urol 2020;20:55. [PMID: 32410612 DOI: 10.1186/s12894-020-00621-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Noblett K, Crowder C. Neuromodulation. Obstet Gynecol Clin North Am 2021;48:677-88. [PMID: 34416945 DOI: 10.1016/j.ogc.2021.05.018] [Reference Citation Analysis]
21 Kaaki B, Gupta D. Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study. PLoS One 2020;15:e0235961. [PMID: 32645082 DOI: 10.1371/journal.pone.0235961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Benson K, McCrery R, Taylor C, Padron O, Blok B, de Wachter S, Pezzella A, Gruenenfelder J, Pakzad M, Perrouin-Verbe MA, Van Kerrebroeck P, Mangel J, Peters K, Kennelly M, Shapiro A, Lee U, Comiter C, Mueller M, Goldman H, Lane F. One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinence. Neurourol Urodyn 2020;39:1482-8. [PMID: 32339339 DOI: 10.1002/nau.24376] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
23 Dodge NA, Linder BJ. Techniques for optimizing lead placement during sacral neuromodulation. Int Urogynecol J 2020;31:1049-51. [PMID: 31875255 DOI: 10.1007/s00192-019-04208-0] [Reference Citation Analysis]
24 Vriesman MH, Wang L, Park C, Diefenbach KA, Levitt MA, Wood RJ, Alpert SA, Benninga MA, Vaz K, Yacob D, Di Lorenzo C, Lu PL. Comparison of antegrade continence enema treatment and sacral nerve stimulation for children with severe functional constipation and fecal incontinence. Neurogastroenterol Motil 2020;32:e13809. [PMID: 32017325 DOI: 10.1111/nmo.13809] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Wang A, Rourke E, Sebesta E, Dmochowski R. Axonics® system for treatment of overactive bladder syndrome and urinary urgency incontinence. Expert Rev Med Devices 2021;18:727-32. [PMID: 34187274 DOI: 10.1080/17434440.2021.1947794] [Reference Citation Analysis]
26 Lehur PA, Sørensen M, Dudding TC, Knowles CH, de Wachter S, Engelberg S, Matzel KE; European SNM Expert Group. Programming Algorithms for Sacral Neuromodulation: Clinical Practice and Evidence-Recommendations for Day-to-Day Practice. Neuromodulation 2020;23:1121-9. [PMID: 32153080 DOI: 10.1111/ner.13117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
27 Hendrickson WK, Amundsen CL. Sacral neuromodulation: sacral anatomy and optimal lead placement. Int Urogynecol J 2021;32:2545-7. [PMID: 33237358 DOI: 10.1007/s00192-020-04615-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Vaganée D, Voorham J, Van de Borne S, Voorham-van der Zalm P, Fransen E, De Wachter S. Pelvic floor activation upon stimulation of the sacral spinal nerves in sacral neuromodulation patients. Neurourol Urodyn 2020;39:1815-23. [PMID: 32585049 DOI: 10.1002/nau.24425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Alnaim AA 2nd. Management Approach of Pediatric Constipation. Cureus 2021;13:e19157. [PMID: 34868789 DOI: 10.7759/cureus.19157] [Reference Citation Analysis]
30 Manjunath A, Keeter MK, Koloms K, Kielb SJ. Abdominal Versus Standard Placement of the Sacral Nerve Stimulator Implantable Pulse Generator. Urology 2019;127:49-52. [PMID: 30794909 DOI: 10.1016/j.urology.2019.02.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Szymański JK, Słabuszewska-Jóźwiak A, Jakiel G. Fowler's Syndrome-The Cause of Urinary Retention in Young Women, Often Forgotten, but Significant and Challenging to Treat. Int J Environ Res Public Health 2021;18:3310. [PMID: 33806865 DOI: 10.3390/ijerph18063310] [Reference Citation Analysis]
32 Lehur PA, Christoforidis D, Meurette G. Artificial Sphincters to Treat Severe Fecal Incontinence: Currently in a Deadlock. Dis Colon Rectum 2020;63:1017-9. [PMID: 32692065 DOI: 10.1097/DCR.0000000000001708] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Coelho GM, Machado NC, Carvalho MA, Rego RMP, Vieira SR, Ortolan EVP, Lourenção PLTA. A protocol for an interventional study on the impact of transcutaneous parasacral nerve stimulation in children with functional constipation. Medicine (Baltimore) 2020;99:e23745. [PMID: 33371132 DOI: 10.1097/MD.0000000000023745] [Reference Citation Analysis]
34 Crites-Bachert M, Clark C. Needle Placement: A Guide to Predictable Sensory and Motor Responses Based on Variations in Needle Placement During Sacral Neuromodulation Procedures. Int Neurourol J 2019;23:302-9. [PMID: 31905277 DOI: 10.5213/inj.1938088.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
35 Vriesman MH, Koppen IJN, Camilleri M, Di Lorenzo C, Benninga MA. Management of functional constipation in children and adults. Nat Rev Gastroenterol Hepatol 2020;17:21-39. [PMID: 31690829 DOI: 10.1038/s41575-019-0222-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
36 Vaganée D, Van de Borne S, Fransen E, Voorham J, Voorham‐van der Zalm P, De Wachter S. Repeatability of tools to assist in the follow up and troubleshooting of sacral neuromodulation patients using the sensory response. Neurourology and Urodynamics 2019;38:801-8. [DOI: 10.1002/nau.23925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
37 Pericolini M, Miget G, Hentzen C, Finazzi Agrò E, Chesnel C, Lagnau P, Haddad R, Grasland M, Amarenco G. Cortical, Spinal, Sacral, and Peripheral Neuromodulations as Therapeutic Approaches for the Treatment of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients: A Review. Neuromodulation 2021. [PMID: 34496454 DOI: 10.1111/ner.13525] [Reference Citation Analysis]
38 Dudding TC, Lehur PA, Sørensen M, Engelberg S, Bertapelle MP, Chartier-Kastler E, Everaert K, Van Kerrebroeck P, Knowles CH, Lundby L, Matzel KE, Muñoz-Duyos A, Rydningen MB, de Wachter S. Reprogramming Sacral Neuromodulation for Sub-Optimal Outcomes: Evidence and Recommendations for Clinical Practice. Neuromodulation 2021. [PMID: 34264542 DOI: 10.1111/ner.13494] [Reference Citation Analysis]
39 Vilanova-Sanchez A, Levitt MA. Surgical Interventions for Functional Constipation: An Update. Eur J Pediatr Surg 2020;30:413-9. [PMID: 32987436 DOI: 10.1055/s-0040-1716729] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Vaganée D, Van de Borne S, Voorham-van der Zalm P, Voorham J, Fransen E, De Wachter S. Pelvic Floor Muscle Electromyography as a Guiding Tool During Lead Placement and (Re)Programming in Sacral Neuromodulation Patients: Validity, Reliability, and Feasibility of the Technique. Neuromodulation 2020;23:1172-9. [PMID: 32558094 DOI: 10.1111/ner.13177] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Al-Shaiji TF. Salvage of a perfectly functioning sacral neuromodulation device (InterStim™) with asymptomatic tined lead wire skin exposure. J Surg Case Rep 2021;2021:rjab310. [PMID: 34316349 DOI: 10.1093/jscr/rjab310] [Reference Citation Analysis]
42 Ghijselings L, Pauwaert K, Verla W, Beeckman D, Van de Putte D, Pattyn P, Everaert K. Primary care providers' knowledge about the therapeutic management of refractory pelvic floor dysfunctions in Flanders, Belgium: a cross-sectional study. Acta Chir Belg 2021;121:386-93. [PMID: 32644014 DOI: 10.1080/00015458.2020.1794338] [Reference Citation Analysis]
43 Ghijselings L, Van De Putte D, Hervé F, Goessaert AS, Beeckman D, Pattyn P, Everaert K. The OptiLUTS trial: improving care for therapy-resistant symptoms of the pelvis in Belgium. Acta Clin Belg 2020;75:334-9. [PMID: 31210620 DOI: 10.1080/17843286.2019.1630109] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Gamé X, Phé V. [Treatment for refractory non-neurogenic overactive bladder]. Prog Urol 2020;30:920-30. [PMID: 33220820 DOI: 10.1016/j.purol.2020.09.004] [Reference Citation Analysis]
45 Wagner L, Alonso S, Le Normand L, Faix A, Kabani S, Castelli C, Gamé X, Cornu J, Bey E. Unilateral versus bilateral sacral neuromodulation test in the treatment of refractory idiopathic overactive bladder: A randomized controlled pilot trial. Neurourology and Urodynamics 2020;39:2230-7. [DOI: 10.1002/nau.24476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]